US Congress House Bill 7296 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 34-1)
Status: Introduced on June 22 2020 - 25% progression, died in committee
Action: 2020-06-22 - Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]

Imposes licensing and price restrictions on federally supported drugs and other medicines intended to address COVID-19 (i.e., coronavirus disease 2019) or other public health emergencies. With respect to a COVID-19 drug patent developed using certain types of federal support, any license granted by the federal government shall be open and nonexclusive. Similarly, a licensee or assignee for such a patent shall grant open nonexclusive licenses for the patent. An entity that receives a license shall pay reasonable royalties to (1) the patent holder, or (2) the owner of marketing exclusivity rights granted by the Food and Drug Administration (FDA) that were terminated under this bill. The bill requires that such drugs be offered at a fair and reasonable price based on certain considerations, such as access. If the Department of Health and Human Services (HHS) finds that the price of any drug to address a public health emergency is excessive, HHS must void any FDA-granted exclusivity for the drug and grant open and nonexclusive licenses to other manufacturers. Such licenses are subject to reasonable royalty requirements.

MMAPPP Act of 2020 Make Medications Affordable by Preventing Pandemic Price gouging Act of 2020

Rep. Janice Schakowsky [D-IL]	Rep. Francis Rooney [R-FL]	Rep. Lloyd Doggett [D-TX]	Rep. Rosa DeLauro [D-CT]
Rep. Peter DeFazio [D-OR]	Rep. Mark Pocan [D-WI]	Rep. Pramila Jayapal [D-WA]	Rep. Nydia Velazquez [D-NY]
Rep. Sanford Bishop [D-GA]	Rep. Eleanor Norton [D-DC]	Rep. Jahana Hayes [D-CT]	Sen. Peter Welch [D-VT]
Rep. Betty McCollum [D-MN]	Rep. Chellie Pingree [D-ME]	Rep. Andre Carson [D-IN]	Rep. Jamie Raskin [D-MD]
Rep. Steve Cohen [D-TN]	Rep. Jared Huffman [D-CA]	Rep. Katie Porter [D-CA]	Rep. Mary Gay Scanlon [D-PA]
Rep. Ro Khanna [D-CA]	Rep. Michael San Nicolas [D-GU]	Rep. Grace Napolitano [D-CA]	Rep. Elaine Luria [D-VA]
Rep. Alcee Hastings [D-FL]	Rep. Tulsi Gabbard [D-HI]	Rep. Judy Chu [D-CA]	Rep. Mark DeSaulnier [D-CA]
Rep. Al Lawson [D-FL]	Rep. Max Rose [D-NY]	Rep. Raul Grijalva [D-AZ]	Rep. Dwight Evans [D-PA]
Rep. David Price [D-NC]	Rep. Dina Titus [D-NV]	Rep. Dean Phillips [D-MN]

Date	Chamber	Action
2020-06-22	House	Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2020-06-22	House	Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2020-06-22	House	Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2020-06-22	House	Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Science, Space, and Technology, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2020-06-22	House	Introduced in House

SB4439 (Related) 2020-08-05 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Type	Source
Summary	https://www.congress.gov/bill/116th-congress/house-bill/7296/all-info
Text	https://www.congress.gov/116/bills/hr7296/BILLS-116hr7296ih.pdf